Back to results
US 6,855,804 B2Granted
Covalently reactive transition state analogs and methods of use thereof
AssigneeBoard of Regents, The University of Texas System
InventorsSudhir Paul, Yasuhiro Nishiyama
Life of this patent
Estimating the term…
Abstract
Improved methods for the production, selection and inhibition of catalytic antibodies are disclosed.
Claims10
A covalently reactive transition state antigen analog (CRTSA), comprising the following structural formula:
- R1-E-R2
- wherein R1 is a peptide sequence of an epitope of a target protein antigen, E is an electrophilic covalently reactive center bearing a partial or full negative charge and R2 is an electron withdrawing or electron donating substituent, R2 optionally further comprising a flanking peptide sequence, further comprising Y between R1 and E, wherein Y is a positively charged amino acid adjacent to the electrophilic center selected from the group consisting of lysine, arginine or analogs thereof.
Dependencies are inferred from the claim text.